131 related articles for article (PubMed ID: 11307752)
1. Nedocromil sodium versus sodium cromoglycate in treatment of exercise-induced bronchoconstriction: a systematic review.
Kelly KD; Spooner CH; Rowe BH
Eur Respir J; 2001 Jan; 17(1):39-45. PubMed ID: 11307752
[TBL] [Abstract][Full Text] [Related]
2. Nedocromil sodium vs. sodium cromoglycate for preventing exercise-induced bronchoconstriction in asthmatics.
Kelly K; Spooner CH; Rowe BH
Cochrane Database Syst Rev; 2000; 2000(4):CD002731. PubMed ID: 11034750
[TBL] [Abstract][Full Text] [Related]
3. Mast-cell stabilising agents to prevent exercise-induced bronchoconstriction.
Spooner CH; Spooner GR; Rowe BH
Cochrane Database Syst Rev; 2003; 2003(4):CD002307. PubMed ID: 14583951
[TBL] [Abstract][Full Text] [Related]
4. Nedocromil sodium vs. sodium cromoglycate pressurized aerosol in the prevention of bronchoconstriction induced by ultrasonic nebulized distilled water in asthmatic children.
Spezia E; Del Col G; Richelli C; Sette L; Boner AL
Pediatr Pulmonol; 1993 Oct; 16(4):243-7. PubMed ID: 8265272
[TBL] [Abstract][Full Text] [Related]
5. Nedocromil sodium in the treatment of exercise-induced asthma: a meta-analysis.
Spooner C; Rowe BH; Saunders LD
Eur Respir J; 2000 Jul; 16(1):30-7. PubMed ID: 10933081
[TBL] [Abstract][Full Text] [Related]
6. Nedocromil sodium for preventing exercise-induced bronchoconstriction.
Spooner CH; Saunders LD; Rowe BH
Cochrane Database Syst Rev; 2002; (1):CD001183. PubMed ID: 11869595
[TBL] [Abstract][Full Text] [Related]
7. Comparison of nedocromil sodium and sodium cromoglycate administered by pressurized aerosol, with and without a spacer device in exercise-induced asthma in children.
Comis A; Valletta EA; Sette L; Andreoli A; Boner AL
Eur Respir J; 1993 Apr; 6(4):523-6. PubMed ID: 8387933
[TBL] [Abstract][Full Text] [Related]
8. Attenuation of aspirin-induced bronchoconstriction by sodium cromoglycate and nedocromil sodium.
Robuschi M; Gambaro G; Sestini P; Pieroni MG; Refini RM; Vaghi A; Bianco S
Am J Respir Crit Care Med; 1997 Apr; 155(4):1461-4. PubMed ID: 9105094
[TBL] [Abstract][Full Text] [Related]
9. Attenuation of exercise induced asthma by nedocromil sodium and sodium cromoglycate.
Sinclair DG; Winfield CR
J R Army Med Corps; 1990 Jun; 136(2):105-6. PubMed ID: 2167369
[TBL] [Abstract][Full Text] [Related]
10. Preventive effect of 2 and 10 mg of sodium cromoglycate on exercise-induced bronchoconstriction.
Storm van's Gravesande K; Mattes J; Grossklauss E; Zurmühl A; Moseler M; Kühr J
Eur J Pediatr; 2000 Oct; 159(10):759-63. PubMed ID: 11039131
[TBL] [Abstract][Full Text] [Related]
11. Inhaled corticosteroids compared to placebo for prevention of exercise induced bronchoconstriction.
Koh MS; Tee A; Lasserson TJ; Irving LB
Cochrane Database Syst Rev; 2007 Jul; 2007(3):CD002739. PubMed ID: 17636704
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of exercise-induced-asthma (EIA) by nedocromil sodium and sodium cromoglycate in children.
Novembre E; Frongia GF; Veneruso G; Vierucci A
Pediatr Allergy Immunol; 1994 May; 5(2):107-10. PubMed ID: 8087189
[TBL] [Abstract][Full Text] [Related]
13. Combination drug therapy for the prevention of exercise-induced bronchoconstriction in children.
de Benedictis FM; Tuteri G; Pazzelli P; Solinas LF; Niccoli A; Parente C
Ann Allergy Asthma Immunol; 1998 Apr; 80(4):352-6. PubMed ID: 9564987
[TBL] [Abstract][Full Text] [Related]
14. Comparative study of the effects of nedocromil sodium (4 mg) and sodium cromoglycate (10 mg) on adenosine-induced bronchoconstriction in asthmatic subjects.
Crimi N; Palermo F; Oliveri R; Vancheri C; Polosa R; Palermo B; Maccarrone C; Mistretta A
Clin Allergy; 1988 Jul; 18(4):367-74. PubMed ID: 2843305
[TBL] [Abstract][Full Text] [Related]
15. Change in osmolarity of disodium cromoglycate solution and protection against exercise-induced bronchospasm in children with asthma.
Kano S; Hirose T; Nishima S
Eur Respir J; 1996 Sep; 9(9):1891-5. PubMed ID: 8880108
[TBL] [Abstract][Full Text] [Related]
16. Single-dose agents in the prevention of exercise-induced asthma: a descriptive review.
Anderson SD
Treat Respir Med; 2004; 3(6):365-79. PubMed ID: 15658883
[TBL] [Abstract][Full Text] [Related]
17. Nedocromil sodium is more potent than sodium cromoglycate against AMP-induced bronchoconstriction in atopic asthmatic subjects.
Richards R; Phillips GD; Holgate ST
Clin Exp Allergy; 1989 May; 19(3):285-91. PubMed ID: 2544248
[TBL] [Abstract][Full Text] [Related]
18. Nedocromil and exercise-induced asthma: acute and chronic effects.
Kivity S; Onn A; Greif Y; Fireman E; Pomeranz S; Topilsky M
Isr Med Assoc J; 1999 Oct; 1(2):92-4. PubMed ID: 10731304
[TBL] [Abstract][Full Text] [Related]
19. Nedocromil sodium for preventing exercise-induced bronchoconstriction.
Spooner CH; Saunders LD; Rowe BH
Cochrane Database Syst Rev; 2000; 2002(2):CD001183. PubMed ID: 10796616
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of fog-induced bronchoconstriction by nedocromil sodium and sodium cromoglycate in intrinsic asthma: a double-blind, placebo-controlled study.
del Bufalo C; Fasano L; Patalano F; Gunella G
Respiration; 1989; 55(3):181-5. PubMed ID: 2554440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
